AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2025 Earnings Call Transcript May 8, 2025
AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.17.
Operator: Good afternoon, and welcome to AbCellera’s First Quarter 2025 Business Update and Conference Call. My name is Jasmine, and I will facilitate the audio portion of today’s interactive broadcast. All lines will be muted during the presentation portion of the call with an opportunity for...
